Author

Shannon M. Buckley

University of UtahORCID 0000-0002-0523-2893Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 4 Organism:human· 4 Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:long-read sequencing· 1

Frequent Co-Authors

Kasidy K. Dobish· 3 shared Carrie Winship· 2 shared Julie Marie VoseiD· 2 shared R. Katherine HydeiD· 2 shared Samantha A. SwensoniD· 2 shared Timothy C. GreineriD· 2 shared Adnan MansooriD· 1 shared Alexander EthelliD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Kasidy K. Dobish

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Proteome landscape of B-cell malignancies identifies mantle cell lymphoma protein signature

Samantha A. Swenson, Carrie Winship, Kasidy K. Dobish, Karli J. Wittorf, Henry C.-H. Law, Julie Marie Vose, Timothy C. Greiner, Michael R. Green, Nicholas T. Woods, Shannon M. Buckley

The paper identifies a proteomic signature of mantle cell lymphoma (MCL) using quantitative proteomics, revealing 10 upregulated proteins that may serve as therapeutic targets.

bioRxiv · Apr 27, 2026 · PreprintCancer Biology

The Splicing Factor PTBP1 interacts with RUNX1 and is Required for Leukemia Cell Survival

Arjun Dhir, Alexander Ethell, Riley Watkins, Calvin K. Lam, Kevin Tur-Rodriguez, Jimmie Persinger, Kasidy K. Dobish, Sipra Panda, Shannon M. Buckley, Samantha A. Swenson, Sandipan Brahma, M. Jordan Rowley, R. Katherine Hyde

The paper identifies PTBP1 as a RUNX1 interacting partner required for leukemia cell survival through metabolic gene regulation.

Leukemia · Nov 10, 2025Peer-reviewedCancer Biology

Small molecule targeting of FBXO21 mediated p85αubiquitylation in acute myeloid leukemia

Kasidy K. Dobish, Suchita Vishwakarma, Hendrik C. Peters, Carrie Winship, Danielle Alvarado, R. Katherine Hyde, Amarnath Natarajan, Shannon M. Buckley

The paper identifies FBXO21 as a therapeutic target in AML by developing a small molecule that inhibits p85 ubiquitination, reducing PI3K pathway activity and inducing cell death.

bioRxiv · Dec 13, 2024 · PreprintCancer Biology

Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma

Man Chun John Ma, Saber Tadros, Alyssa C. Bouska, Tayla B. Heavican, Haopeng Yang, Qing Deng, Dalia Y. Moore, Ariz Akhter, Keenan T. Hartert, Neeraj Kumar Jain, Jordan Showell, Sreejoyee Ghosh, Lesley E. Street, Marta Beata Davidson, Christopher Daniel Carey, , Michael R. Green

This study identifies subtype-specific and co-occurring genetic alterations across major B-NHL subtypes using targeted sequencing of 380 genes in 685 tumors.

Haematologica · Apr 1, 2021Peer-reviewedGenomics